Business Context and Reporting Period
This Form 8-K is a current report filed by Sonus Pharmaceuticals, Inc. on November 3, 2004. The filing serves to announce the company's financial results for the fiscal quarter ended September 30, 2004. The report incorporates a press release (Exhibit 99.1) by reference but explicitly states that the press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), the text of which is not included in the provided source document.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It only confirms the issuance of a press release regarding the Q3 2004 results.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. Such information would be located in the referenced press release.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing the attached Exhibit 99.1 Press Release.
- Confirm the company name discrepancy: The filing metadata lists "ACHIEVE LIFE SCIENCES, INC.", but the document text identifies the registrant as Sonus Pharmaceuticals, Inc.
- Note that the press release is incorporated by reference but is not legally deemed "filed" for liability purposes under Section 18 of the Exchange Act.